CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year

GlobeNewswire•April 03, 2018 OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened its leadership team with biopharmaceutical expertise, secured additional financing, and boosted nutraceutical product distribution, while advancing towards the launch of its first pharmaceutical CUREfilm™ product. “We…